Skye Bioscience Growth Metrics (2012-2014) | SKYE

Growth Metrics Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014
Growth Ratios
Assets Growth (1y) 239.74%-8.66%
Assets (QoQ) -4.00%12.95%-3.33%-12.86%
Capital Expenditures (QoQ) 56.13%0.00%
Cash & Equivalents Growth (1y) 183.99%97.64%99.80%68.12%
Cash & Equivalents (QoQ) 101.83%-11.90%27.73%25.04%40.47%-10.94%7.48%
Cash from Investing Activities Growth (1y) -10,767.02%
Cash from Investing Activities (QoQ) -56.13%6.16%
Cash from Operations Growth (1y) -15,960.00%-674.16%66.81%120.61%
Cash from Operations (QoQ) 2,672.73%-918.95%-28.69%45.73%-0.38%52.66%179.93%
EBITDA Margin Growth (1y) 890.00-2175.00
EBITDA Margin (QoQ) 1,416.00173.00-1141.00443.00-1650.00
EBIT Growth (1y) 900.00%-210.80%80.14%-471.84%
EBIT Margin Growth (1y) 890.00-2175.00
EBIT Margin (QoQ) 1,416.00-250.00-718.00443.00-1650.00
EBIT (QoQ) 5,218.28%-230.13%158.31%-79.40%-808.87%76.68%-991.95%
EBT Growth (1y) -2,841.82%-212.42%1,395.87%-532.45%
EBT Margin Growth (1y) 528.00-2142.00
EBT Margin (QoQ) 245.00-452.00-500.001,236.00-2426.00
EBT (QoQ) 8,812.73%-95.06%1,191.32%-148.26%-265.45%165.69%-473.31%
Enterprise Value Growth (1y) -183.99%-97.64%-99.80%-68.12%
Enterprise Value (QoQ) -101.83%11.90%-27.73%-25.04%-40.47%10.94%-7.48%
EPS (Basic) Growth (1y) -1,056.26%-184.08%1,750.40%-667.36%
EPS (Basic) (QoQ) 8,783.13%-97.43%1,117.53%-134.41%-681.04%156.54%-473.31%
FCF Margin Growth (1y) 9,842.008,734.00
FCF Margin (QoQ) 2,216.00-808.008,031.00403.001,108.00
Free Cash Flow Growth (1y) -150,716.36%-674.16%93.09%103.67%
Free Cash Flow (QoQ) 2,672.73%-4,031.80%-50.41%8.15%89.43%52.66%179.93%
Gross Margin Growth (1y) -536.00-298.00
Gross Margin (QoQ) -264.00-110.0063.00-225.00-27.00
Gross Profit Growth (1y) 3.83%-35.62%
Gross Profit (QoQ) 84.59%-17.47%-8.39%-25.61%14.45%
Interest Coverage Ratio Growth (1y) 89.68%-886.08%
Interest Coverage Ratio (QoQ) 119.14%-79.81%-847.25%64.28%-1,358.31%
Net Cash Flow Growth (1y) 5,154.74%885.90%-81.67%-88.30%
Net Cash Flow (QoQ) 115.70%-306.10%1,045.34%25.04%-59.53%-137.98%160.88%
Net Income Growth (1y) -1,394.55%-212.42%2,162.50%-753.17%
Net Income (QoQ) 8,812.73%-96.74%1,193.13%-134.41%-674.02%165.69%-473.31%
Net Income towards Common Stockholders Growth (1y) -1,394.55%-212.42%2,162.50%-753.17%
Net Income towards Common Stockholders (QoQ) 8,812.73%-96.74%1,193.13%-134.41%-674.02%165.69%-473.31%
Net Margin Growth (1y) 543.00-2045.00
Net Margin (QoQ) 162.00-268.00-587.001,236.00-2426.00
Operating Income Growth (1y) 900.00%-210.80%80.14%-471.84%
Operating Income (QoQ) 5,218.28%-230.13%158.31%-79.40%-808.87%76.68%-991.95%
Operating Margin Growth (1y) 890.00-2175.00
Operating Margin (QoQ) 1,416.00-250.00-718.00443.00-1650.00
Profit After Tax Growth (1y) -1,394.55%-211.02%2,162.50%-753.17%
Profit After Tax (QoQ) 8,365.45%-96.56%1,193.13%-134.41%-625.98%170.03%-473.31%
Property, Plant & Equipment (Net) Growth (1y) -49.89%
Property, Plant & Equipment (Net) (QoQ) -39.64%-5.66%-6.00%-6.38%
Return on Assets (QoQ) -8.003.00-12.00
Return on Capital Employed (QoQ) 7.00-21.00
Return on Equity (QoQ) -15.005.00-19.00
Return on Sales Growth (1y) 5.00-20.00
Return on Sales (QoQ) 2.00-3.00-6.0012.00-24.00
Revenue Growth (1y) 11.01%-33.13%
Revenue (QoQ) 90.67%-16.32%-9.11%-23.45%14.85%
Shareholder's Equity Growth (1y) 116.23%11.88%
Shareholder's Equity (QoQ) -1.28%28.78%4.34%-15.65%
Tax Rate (QoQ) -9.001,899.00